Genomics Meets Big Pharma: How Drug Companies are Betting on Pharmacogenomics
The advent of pharmacogenomics in drug development heralds a paradigm shift within the pharmaceutical sector. This evolution is driven by the increasing prominence…
Pharmacogenomics in the Age of AI: Merging Genetics with Machine Learning for Tailored Treatments
As early as 2011, the potential of big data science in healthcare was foreseen as transformative for the next decade1. This prophecy has…
Pharmacogenomics and Rare Diseases: Bringing Hope to Orphan Drug Development
Rare diseases are a significant global health challenge, affecting millions worldwide. In the US, 30 million people, and in the EU, 36 million,…
Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
The Role of Pharmacogenomics in Addressing Racial and Ethnic Health Disparities
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in underprivileged communities remains a pressing area…
Assessment of the Clinical Validity of Pharmacogenomics in Pain Management.
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
Lessons from COVID-19: Pharmacogenomics in Preparing for Future Pandemics
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
PGx-Guided Antiplatelet Therapy: Reducing Bleeding Risks with Personalized Dosing
Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.
The Rise of Polygenic Risk Scores: Can PGx Predict Susceptibility to Medication Side Effects?
Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.
The Lifeline of PGx and Factor V Leiden
Explore how PGx and Factor V Leiden intertwine to influence medication efficacy and safety for those with genetic clotting disorders.
End of content
End of content